174 related articles for article (PubMed ID: 33289114)
1. Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Huang Z; Shui X; Ling Y; Zhou L; Shi W; Luo Y; Li S; Zhu J; Yu S; Liu J
Clin Cardiol; 2020 Dec; 44(2):176-85. PubMed ID: 33289114
[TBL] [Abstract][Full Text] [Related]
2. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
3. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
4. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
5. Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Yin YJ; Chen YC; Xu L; Zhao XH; Song Yang
Int J Cardiol Heart Vasc; 2020 Jun; 28():100541. PubMed ID: 32490148
[TBL] [Abstract][Full Text] [Related]
6. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention.
Wang Y; Zhang HW; Guo YL; Zhu CG; Wu NQ; Li JJ
Postgrad Med J; 2019 Jan; 95(1119):18-22. PubMed ID: 30700582
[TBL] [Abstract][Full Text] [Related]
8. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
11. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
[TBL] [Abstract][Full Text] [Related]
12. The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Qing P; Wu NQ; Xu B; Gao RL
Clin Cardiol; 2014 Sep; 37(9):558-65. PubMed ID: 25113039
[TBL] [Abstract][Full Text] [Related]
13. Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
PLoS One; 2014; 9(7):e101719. PubMed ID: 24988213
[TBL] [Abstract][Full Text] [Related]
14. Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention.
Song L; Wang Y; Guan C; Zou T; Sun Z; Xie L; Zhang R; Dou K; Yang W; Wu Y; Qiao S; Xu B
Circ Cardiovasc Interv; 2021 Nov; 14(11):e010923. PubMed ID: 34674557
[TBL] [Abstract][Full Text] [Related]
15. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
Maadani M; Sarraf NS; Alilou S; Aeinfar K; Sadeghipour P; Zahedmehr A; Fathollahi MS; Hashemi Ghadi SI; Zavarehee A; Zolfaghari M; Zolfaghari R
Tex Heart Inst J; 2022 Nov; 49(6):. PubMed ID: 36515930
[TBL] [Abstract][Full Text] [Related]
17. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
[TBL] [Abstract][Full Text] [Related]
18. Effects of bilirubin on perioperative myocardial infarction and its long-term prognosis in patients undergoing percutaneous coronary intervention.
Li Y; Li DB; Zhao LD; Lv QB; Wang Y; Ren YF; Zhang WB
World J Clin Cases; 2022 Feb; 10(6):1775-1786. PubMed ID: 35317137
[TBL] [Abstract][Full Text] [Related]
19. Postdischarge prognostic significance of periprocedural myocardial injury after percutaneous intervention of chronic total occlusion.
Poels E; Vanhaverbeke M; van den Buijs D; Cottens D; Ameloot K; Lesizza P; McCutcheon K; Bennet J; Dens J
Open Heart; 2022 Dec; 9(2):. PubMed ID: 36600648
[TBL] [Abstract][Full Text] [Related]
20. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
